Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia

MLA

Peter L Kristensen, et al. “Impact of the TCF7L2 Genotype on Risk of Hypoglycaemia and Glucagon Secretion during Hypoglycaemia.” Endocrinology, Diabetes & Metabolism Case Reports, vol. 5, no. 6, Nov. 2016, pp. 53–60. EBSCOhost, https://doi.org/10.1530/EC-16-0050.

APA

Peter L Kristensen, Ulrik Pedersen-Bjergaard, Rikke Due-Andersen, Thomas Høi-Hansen, Lise Grimmeshave, Valeriya Lyssenko, Leif Groop, Jens J Holst, Allan A Vaag, & Birger Thorsteinsson. (2016). Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia. Endocrinology, Diabetes & Metabolism Case Reports, 5(6), 53–60. https://doi.org/10.1530/EC-16-0050

Chicago

Peter L Kristensen, Ulrik Pedersen-Bjergaard, Rikke Due-Andersen, Thomas Høi-Hansen, Lise Grimmeshave, Valeriya Lyssenko, Leif Groop, Jens J Holst, Allan A Vaag, and Birger Thorsteinsson. 2016. “Impact of the TCF7L2 Genotype on Risk of Hypoglycaemia and Glucagon Secretion during Hypoglycaemia.” Endocrinology, Diabetes & Metabolism Case Reports 5 (6): 53–60. doi:10.1530/EC-16-0050.